Andrew J. Cowan, MD
Associate Professor
Clinical Research Division, Fred Hutch
Clinical Director
Myeloma Service, Fred Hutch
Member
Immunotherapy Integrated Research Center (IIRC), Fred Hutch
Dr. Andrew Cowan is a hematologist-oncologist who specializes in treating patients with multiple myeloma and other blood disorders. He leads clinical trials of new treatments for these diseases, including the use of engineered immune cells, combination strategies and genomics data. An expert in trial design, Dr. Cowan evaluates research proposals as a member of Fred Hutch's Scientific Review Committee.
Other Appointments & Affiliations
Physician, Fred HutchPhysician
Fred Hutch
Associate Professor of Medicine, Division of Hematology and Oncology
University of Washington School of Medicine
Active Full Member
American Society of Hematology (ASH)
Active Full Member
American Society for Blood and Marrow Transplantation (ASBMT)
Education
University of Washington, MD, Fellowship
Research Interests
Multiple Myeloma
Amyloidosis
Clinical Expertise
Multiple myeloma
AL amyloidosis treatment
"The foundation of a cancer success story is teamwork."
— Dr. Andrew J. Cowan